We are live on ! Find out more
AAMU

AEGON Asset Management (UK) Portfolio holdings

AUM $9.38B
1-Year Est. Return 48.94%
This Fund
S&P 500
This Quarter Est. Return
-4.59%
1 Year Est. Return
+48.94%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$4.95B
AUM Growth
-$364M
Cap. Flow
-$73.1M
Cap. Flow %
-1.48%
Top 10 Hldgs %
36.53%
Holding
172
New
Increased
29
Reduced
86
Closed
8

Top Buys

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$27.2M
2
DHR icon
Danaher
DHR
+$21.8M
3
BMY icon
Bristol-Myers Squibb
BMY
+$20.1M
4
PEP icon
PepsiCo
PEP
+$18.9M
5
AGCO icon
AGCO
AGCO
+$6.22M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$36.1M
2
MRK icon
Merck
MRK
+$15.4M
3
ILMN icon
Illumina
ILMN
+$15.1M
4
PFE icon
Pfizer
PFE
+$13.8M
5
SWK icon
Stanley Black & Decker
SWK
+$11.3M

Sector Composition

Rank Sector Weight
1 Technology 33.9%
2 Healthcare 13.43%
3 Financials 12.6%
4 Industrials 9.04%
5 Consumer Discretionary 6.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MSFT icon
1
Microsoft
MSFT
$2.9T
$451M 9.13%
1,937,838
-7,550
-0.4% -$1.99M
AAPL icon
2
Apple
AAPL
$4.97T
$402M 8.12%
2,909,012
-230,086
-7% -$36.1M
AMZN icon
3
Amazon
AMZN
$2.44T
$151M 3.05%
1,333,471
-17,885
-1% -$2.26M
GOOG icon
4
Alphabet (Google) Class C
GOOG
$4.11T
$136M 2.74%
1,410,135
-2,745
-0.2% -$307K
NEE icon
5
NextEra Energy
NEE
$184B
$121M 2.44%
1,537,056
-8,307
-0.5% -$705K
AVGO icon
6
Broadcom
AVGO
$1.76T
$117M 2.36%
2,626,640
-21,550
-0.8% -$1.1M
V icon
7
Visa
V
$701B
$111M 2.24%
622,639
-964
-0.2% -$196K
PFE icon
8
Pfizer
PFE
$143B
$110M 2.22%
2,502,420
-284,996
-10% -$13.8M
MRK icon
9
Merck
MRK
$322B
$108M 2.18%
1,249,879
-172,486
-12% -$15.4M
ADP icon
10
Automatic Data Processing
ADP
$109B
$102M 2.06%
450,119
-3,367
-0.7% -$794K
JPM icon
11
JPMorgan Chase
JPM
$916B
$97.4M 1.97%
931,008
-37,550
-4% -$4.31M
PEP icon
12
PepsiCo
PEP
$196B
$92.9M 1.88%
568,322
+109,906
+24% +$18.9M
NVDA icon
13
NVIDIA
NVDA
$4.6T
$85.6M 1.73%
7,055,660
+18,760
+0.3% +$297K
FRC
14
DELISTED
First Republic Bank
FRC
$81.9M 1.66%
627,143
-13,562
-2% -$2.08M
GILD icon
15
Gilead Sciences
GILD
$165B
$79.9M 1.62%
1,294,026
-3,200
-0.2% -$202K
BMY icon
16
Bristol-Myers Squibb
BMY
$129B
$78.5M 1.59%
1,103,766
+277,717
+34% +$20.1M
CME icon
17
CME Group
CME
$95.4B
$76.9M 1.55%
433,760
-1,582
-0.4% -$313K
RSG icon
18
Republic Services
RSG
$67.4B
$74.7M 1.51%
549,078
DHR icon
19
Danaher
DHR
$138B
$71.7M 1.45%
312,816
+88,955
+40% +$21.8M
SEDG icon
20
SolarEdge
SEDG
$2.37B
$69M 1.39%
297,955
+115
+0% +$33.9K
TSM icon
21
TSMC
TSM
$1.94T
$68.6M 1.39%
998,387
-8,119
-0.8% -$671K
ALB icon
22
Albemarle
ALB
$13.4B
$65M 1.31%
245,660
-804
-0.3% -$204K
TTEK icon
23
Tetra Tech
TTEK
$8.77B
$62M 1.25%
2,413,010
-73,840
-3% -$2.07M
MS icon
24
Morgan Stanley
MS
$319B
$61.2M 1.24%
774,227
-4,935
-0.6% -$416K
MET icon
25
MetLife
MET
$62.4B
$60.1M 1.22%
988,033

Similar funds

AEGON Asset Management (UK)'s Q3 2022 Portfolio in Review

As of Q3 2022, AEGON Asset Management (UK) held 172 positions worth $4.95B, down 6.8% from $5.31B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Trading was light in Q3 2022: portfolio turnover was 4.7%. AEGON Asset Management (UK) opened no new positions and exited 8, leaving the 172-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 34% of assets, down from 35% a quarter earlier, followed by Healthcare and Financials.

  • AEGON Asset Management (UK) added most to Johnson & Johnson in Q3 2022, an estimated $27.2M increase.
  • AEGON Asset Management (UK)'s biggest Q3 2022 reduction was Apple, cutting an estimated $36.1M.
  • AEGON Asset Management (UK) fully exited Illumina in Q3 2022, selling an estimated $15.1M.
  • AEGON Asset Management (UK)'s ten largest holdings make up 37% of its $4.95B portfolio in Q3 2022.
  • AEGON Asset Management (UK) opened 0 new positions and closed 8 in Q3 2022.
  • AEGON Asset Management (UK)'s portfolio value fell 6.8% quarter-over-quarter to $4.95B.

Based on AEGON Asset Management (UK)'s 13F filing for Q3 2022, filed 18 Oct 2022.